Hemoglobin News and Research

RSS

Iron deficiency common among pregnant women despite supplements

When a woman becomes pregnant, her iron requirements increase almost tenfold to support fetal development as well as her own increased iron needs.

26 Sep 2024

Noninvasive imaging reveals impact of diet on cardiovascular health

The dynamics of blood nutrient and lipid levels after consuming a high-fat meal are crucial indicators of both current and future cardiovascular health. Traditionally, measuring these circulating substances has involved invasive blood draws, which are not feasible for regular health tracking.

26 Sep 2024

Study links youth prediabetes to increased pregnancy risks later in life

New research conducted at Columbia Mailman School of Public Health and Mount Sinai School of Medicine shows a link between prediabetes among young people and adverse pregnancy outcomes later in life.

24 Sep 2024

Targeted obesity programs reduce lipid-related heart disease risk in children

Researchers assess the lipid profiles of obese children and adolescents and their health implications.

24 Sep 2024

Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases

A genetic connection between cardiovascular disease and psoriasis highlights shared inflammatory pathways, emphasizing the need for cardiovascular monitoring.

19 Sep 2024

Clinical trial demonstrates effectiveness of drip iron for anemia

Researchers found that a medicine called ferric carboxymaltose given in drip through the vein works faster and better than an iron tablet taken by mouth for the treatment of anemia – and it is as safe as the tablet. The findings were published in Lancet Global Health.

19 Sep 2024

Extended estrogen suppression treatment found safe for postmenopausal breast cancer patients

New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of coronary artery calcification, a sign of active coronary atherosclerosis, as some prior studies had indicated.

18 Sep 2024

Early pregnancy HbA1c predicts gestational diabetes, reducing the need for complex tests

Early pregnancy HbA1c can predict gestational diabetes and reduce the need for oral glucose tolerance tests, improving screening accessibility in diverse populations.

15 Sep 2024

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the need for additional studies.

13 Sep 2024

Eight-hour eating window improves blood glucose control in prediabetic adults

Restricting the eating window to 8 hours a day significantly improves blood glucose control in adults at risk of type 2 diabetes irrespective of whether it is earlier or later in the day, according to a randomised crossover trial to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

10 Sep 2024

Obesity medication liraglutide safe and effective in children under 12, research finds

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), and published simultaneously in the New England Journal of Medicine (NEJM), has found.

10 Sep 2024

Vitamin D supplementation shows promising impact on cardiometabolic health

A latest systematic review and meta-analysis conducted by scientists from institutions across China and the United States has uncovered promising insights into how vitamin D supplementation can significantly impact cardiometabolic health.

9 Sep 2024

GLP-1 receptor agonists show promise in treating substance use disorders

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences.

9 Sep 2024

Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing

Research shows elevated metformin in diabetic foot ulcer exudates when combined with insulin, highlighting potential for improved wound healing therapies.

9 Sep 2024

Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic

Semaglutide significantly reduces all-cause mortality in non-diabetic obese patients, particularly by lowering infection-related deaths during the COVID-19 pandemic. However, the study's findings should be interpreted with caution due to potential competing risks and unique pandemic circumstances.

5 Sep 2024

Clonal hematopoiesis drives femoral atherosclerosis in middle-aged adults

Researchers reveal that clonal hematopoiesis (CH) significantly increases the risk of developing femoral atherosclerosis, suggesting a unidirectional relationship independent of traditional cardiovascular risk factors.

2 Sep 2024

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Tirzepatide, a once-weekly dual agonist, outperforms long-acting insulin in reducing HbA1c, body weight, and improving cardiovascular markers in Type 2 diabetes patients.

2 Sep 2024

Study finds diabetes linked to accelerated brain aging, but healthy habits can help

The study links diabetes to accelerated brain aging, highlighting lifestyle factors that could mitigate risks, especially for males with cardiometabolic issues.

29 Aug 2024

Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients

A study published in eClinicalMedicine found that tirzepatide outperforms semaglutide in reducing the risk of type 2 diabetes and major cardiovascular events among individuals with obesity, with or without existing diabetes, while also achieving greater weight loss.

28 Aug 2024

GluFormer outperforms existing AI models in predicting blood sugar levels

Study introduces GluFormer, a transformer-based generative model, to predict glycemic patterns using continuous glucose monitoring data, with significant implications for diabetes management and treatment strategies.

26 Aug 2024

Hemoglobin News and Research

Iron deficiency common among pregnant women despite supplements

Noninvasive imaging reveals impact of diet on cardiovascular health

Study links youth prediabetes to increased pregnancy risks later in life

Targeted obesity programs reduce lipid-related heart disease risk in children

Cardiovascular disease pathways associated with psoriasis, but not other immune-mediated diseases

Clinical trial demonstrates effectiveness of drip iron for anemia

Extended estrogen suppression treatment found safe for postmenopausal breast cancer patients

Early pregnancy HbA1c predicts gestational diabetes, reducing the need for complex tests

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Eight-hour eating window improves blood glucose control in prediabetic adults

Obesity medication liraglutide safe and effective in children under 12, research finds

Vitamin D supplementation shows promising impact on cardiometabolic health

GLP-1 receptor agonists show promise in treating substance use disorders

Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing

Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic

Clonal hematopoiesis drives femoral atherosclerosis in middle-aged adults

Tirzepatide outperforms insulin in controlling diabetes and promoting weight loss in clinical trials

Study finds diabetes linked to accelerated brain aging, but healthy habits can help

Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients

GluFormer outperforms existing AI models in predicting blood sugar levels

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News